The outcomes are organized and presented according to the core pathophysiological axes of AD: beginning with metrics of skin barrier integrity, followed by an analysis of cytokines related to Th1/Th2, and measures of important effector cells and systemic sensitization (mast cells and IgE levels in the serum). The gene discussed is IGHE; the disease is Alzheimer disease.